Specialty Chemicals

Page 1

Metabolix Inc closes $25 mln private placement

Monday, 25 Aug 2014 09:00am EDT

Metabolix Inc:Closed its previously announced private placement of $25 million of company securities.Participants in the private placement include Jack W. Schuler, Oracle Investment Management, Inc., Birchview Capital, certain members of the company's Board of Directors and executive management team and other investors.Proceeds from this transaction will be used to continue executing the company's business plan.

Abakan Inc announces financing

Wednesday, 20 Aug 2014 10:42am EDT

Abakan Inc:Determines to initiate private placement of up to 18,750,000 shares of restricted common stock, at price of $0.40 share, for anticipated gross proceeds of up to $7,500,000.To support ongoing operations, retire outstanding debt and bolster product development.The prospective private placement is scheduled to close on Sept. 15, 2014.Full subscription to anticipated proceeds would result in new shareholders having 21.5 pct of company's outstanding shares.Proceeds will be used to pay off or convert over $4.2 mln in debt and to provide working capital needed to progress development of company's Cermaclad coating process for oil and gas, and mining sectors to longer sections of pipe than had been previously accomplished.Also to complete expanded product launch for PComP coatings.PComP expansion includes financing commitment from State of Ohio to match Company's PComP expenditures.Our resulting balance sheet and production scale-up will position the Company for renewed growth.

Acelon Chemicals & Fiber Corp to issue new shares

Wednesday, 13 Aug 2014 09:01pm EDT

Acelon Chemicals & Fiber Corp:To issue 5 million new shares of its common stock.New shares with par value of T$10 per share and tentative issue price at T$20 per share.15 pct of the new shares to be offered to the company's employees.10 pct of the new shares to be offered through public offering.Remaining 75 pct to be offered to the existing shareholder.Proceeds to be used for repaying bank loan and investment in subsidiary.

Metabolix Inc enters into private placement agreement with investors to raise $25 mln in equity financing

Monday, 4 Aug 2014 08:30am EDT

Metabolix Inc:Enters into an agreement with Jack W. Schuler, Oracle Investment Management, Inc., Birchview Capital, certain members of the Company's Board of Directors and executive management team, and other investors for sale of an aggregate of $25 mln of Company securities.Closing of proposed financing is subject to the Company obtaining financial viability exception from certain NASDAQ shareholder approval requirements under Rule 5635(f) of the NASDAQ Stock Market Listing Rules, as well as other customary closing conditions.At closing, the investors will purchase an aggregate of 50 mln units of the Company's securities at a price of $0.50 per unit.Each unit will consist of one share of the Company's Common Stock and one one-thousandth (1/1,000) of a share of the Company's to-be-designated Series B Convertible Preferred Stock.Each share of Preferred Stock issued in the transaction will automatically convert into 1,000 shares of Common Stock upon the effectiveness of the filing of a charter amendment to increase number of shares of the Company's authorized Common Stock to not less than 150,000,000.Purchase of shares by the investors represents a purchase price of $0.25 per share of common stock on an as-converted basis.

Symrise AG to increase company's share capital for Diana acquisition

Monday, 28 Jul 2014 04:23pm EDT

Symrise AG:Says to increase company's share capital of 129,323,300.00 euros to 129,812,574.00 euros by issuing 489,274 new no par value bearer shares from authorized capital.Says capital increase is to acquire French Diana Group.

Cientifica PLC announces issues shares

Friday, 25 Jul 2014 02:00am EDT

Cientifica PLC:Conditionally raised 100,000 Pound through placing of 6,666,667 new ordinary shares of 0.5 pence each in company at 1.5 pence per share.Placing price represents 20 pct discount to closing mid price of Co's ordinary shares on July 24, being latest date prior to release of this announcement.Placing , which has been arranged by Peterhouse Corporate Finance Ltd, Co's broker.Net proceeds of will be applied towards securing investments in line with company's investing strategy.Expected to commence trading on or around July 30.

BioAmber Inc announces pricing of $33.6 mln registered offering

Wednesday, 16 Jul 2014 09:02am EDT

BioAmber Inc:Says it has priced an underwritten registered offering of 2,800,000 shares of its common stock at a price of $12.00 per share, and granted the underwriters in the offering a 30-day option to purchase up to an additional 420,000 shares of its common stock.Gross proceeds to the Company will be $33.6 mln.Offering is expected to close on July 21 subject to customary closing conditions.Credit Suisse Securities (USA) LLC and Canaccord Genuity Inc. are acting as the bookrunning managers for the offering.Net proceeds, after underwriting discounts and commissions and other estimated fees and expenses payable by BioAmber will be about $31.1 mln.BioAmber intends to use net proceeds of the offering for working capital and other general corporate purposes.

BioAmber Inc announces public offering of common stock

Tuesday, 15 Jul 2014 04:05pm EDT

BioAmber Inc:Commences public offering of 2,800,000 shares of common stock.Underwriters will have 30-day option from date of offering to purchase up to an additional 420,000 shares.Credit Suisse Securities (USA) LLC and Canaccord Genuity are bookrunning managers.Intends to use proceeds for working capital and other general corporate purposes.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider: Valuation & Research Specialists
$75.00
Provider: Valuation & Research Specialists
$75.00
Provider: Bohai Securities Co.,Ltd.
$81.00
Provider: Bohai Securities Co.,Ltd.
$35.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.